RK

Rabindra Kumar Lenka

Active Director Director DIN 02014408
DIN 02014408 First appointment Apr 2008 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2008
Shareholding value β€’β€’β€’β€’ Premium profile

About Rabindra Kumar Lenka

Data last updated:

Rabindra Kumar Lenka is a Director at Kamal Hospital & Research Centre Private Limited (since 2008). The company operates in Healthcare.

DIN 02014408
Primary Designation Director
Industry Healthcare
First Appointment 04 Apr 2008
Oldest Company Age 18 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Apr 20082008Active

Board colleagues of Rabindra Kumar Lenka

NameDINCompanyDesignation
Urmila Lenka10923764Kamal Hospital & Research Centre Private LimitedDirector Appointed In Casual Vacancy

Directorship timeline

Open interactive timeline →
Kamal Hospital & Research Centre Private Limited
Premium access

Shareholding and investment profile for Rabindra Kumar Lenka

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rabindra Kumar Lenka

Rabindra Kumar Lenka currently holds 1 directorship: Kamal Hospital & Research Centre Private Limited (Director, since 04 Apr 2008).

Rabindra Kumar Lenka was first appointed on 04 Apr 2008 as Director at Kamal Hospital & Research Centre Private Limited.

The current boards of Rabindra Kumar Lenka's companies include Urmila Lenka (Kamal Hospital & Research Centre Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available